Biden finds 'following the science' isn't so easy
![President Biden.](https://cdn.mos.cms.futurecdn.net/g4NWp5TjcjCE89EAn9brhm-415-80.jpg)
Sometimes, following the science isn't so easy — especially when "the science" is in flux.
That's certainly the case with the Biden administration's plan to roll out COVID-19 booster shots to already-vaccinated individuals. The White House pledged in August to start rolling out the new jabs on a widespread basis starting Sept. 20, but it's increasingly clear that the whole process is more than a bit messy — two FDA vaccine officials resigned last month, reportedly over their opposition to the administration's booster plan, then on Monday joined a larger group of 18 scientists who say there isn't enough data to support a widespread booster campaign.
The implication? President Biden got ahead of the science.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Although the idea of further reducing the number of COVID-19 cases by enhancing immunity in vaccinated people is appealing, any decision to do so should be evidence-based and consider the benefits and risks for individuals and society," the group wrote in The Lancet medical journal.
As New York magazine reports today, there are a number of moving parts in the debate. On the one hand, there are concerns about waning immunity among vaccinated people; on the other hand, those folks still seem to have pretty good protection against severe illness and death. Israel is already giving boosters, and early data suggests that — for older people at least — the extra shots do improve immunity. Then again, the Lancet authors warn that the side effects from boosters given too soon or too frequently could exacerbate the widespread vaccine hesitancy that has helped the pandemic persist in the United States. Complicating all of this: The World Health Organization has warned against a widespread booster campaign while much of the planet is still waiting for its first shot.
What's a president — especially one who has vowed repeatedly to "follow the science" — to do?
When Donald Trump was in charge, it was easy for Democrats to pledge to follow the science on COVID because Trump so plainly didn't, preferring to focus on his own political well-being. But in an ongoing emergency, when scientists themselves can't agree on a course of action — and when there are ethical questions that don't lend themselves to clear "right or wrong" answers — the slogan's insufficiency reveals itself. Even with the best of intentions, politics will still be a factor: Biden's poll ratings are still slipping, and he needs to be seen doing something.
"Follow the science" sounds easy and simple. In the real world, though, the buck doesn't stop in a laboratory, but in the Oval Office.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.
-
Why the UK phone signal is so poor
Under The Radar Having trouble connecting? A lack of investment, planning rules and even your home could be to blame
By Elizabeth Carr-Ellis, The Week UK Published
-
Battleground states to watch in the 2024 election
In Depth These seven states could end up deciding who wins the White House this year
By Justin Klawans, The Week US Published
-
Leave the crowds behind at these 7 sensational hotels
The Week Recommends Traveling in September means more room to explore
By Catherine Garcia, The Week US Published
-
Who will win the 2024 presidential election?
In Depth Election year is here. Who are pollsters and experts predicting to win the White House?
By Justin Klawans, The Week US Published
-
Harris, Biden campaign together at union rally
Speed Read The sitting president and Democratic presidential nominee joined forces in battleground state Pennsylvania
By Peter Weber, The Week US Published
-
What are the lessons from Ukraine's Russia incursion?
Talking Points And what do they mean for Putin's red lines?
By Joel Mathis, The Week US Published
-
'The federal government's response to the latest surge has been tepid at best'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
RFK Jr.'s Trump endorsement: GOP windfall or minor jolt?
Talking Points Some believe RFK Jr. abandoning his presidential bid could be game-changing — others aren't so sure
By Justin Klawans, The Week US Published
-
A brief history of third parties in the US
In Depth Though none of America's third parties have won a presidential election, they have nonetheless had a large impact on the country's politics
By Joel Mathis, The Week US Published
-
How will Kamala Harris' ban on grocery price gouging work?
Talking Points And can it bring down prices?
By Joel Mathis, The Week US Published
-
'Declines haven't happened in most places'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published